Dr Pepper Raises EPS Guidance On Solid Q2 Results
Dr Pepper Snapple (NYSE:DPS) has raised its full-year core EPS guidance, after net sales rose 2% year-over-year on a 1% rise in sales volume in Q2. The company has beaten consensus EPS estimates for four consecutive quarters, and now expects core EPS to be in the $4.27 to $4.35 range, up from the $4.20-$4.30 range forecast previously, in 2016.
In 2015, while 46% and 56% of Coca-Cola and PepsiCo’s net sales came from the U.S., a larger 89% of Dr Pepper’s revenue came from the domestic market. Dr Pepper is more dependent on CSDs than both Coca-Cola and PepsiCo are, with 82% of its net volume in this beverage category. But the company has been able to increase both its volume and revenue in the U.S. CSD market in the last few years despite the slowdown in the overall market, by nabbing market share from its chief competitors. Emphasis on smaller packages is also helping Dr Pepper boost its top line. The company expects around 3 percentage points of positive price and package mix impact on the top line for the full-year, of which around 2.5 points is expected to come from smaller CSD packages and brands such as Snapple, Clamato, and its allied brand portfolio.
- A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly’s Q1
- What Should You Do With Danaher Stock At $250 After Q1 Beat?
- Will A Macau Recovery Drive MGM Stock Higher Following Q1 Results?
- Lockheed Martin Stock Will Likely Remain In Focus After A Stellar Q1
- Up 17% YTD, What To Expect From eBay Q1 Results?
- Rising 21% This Year, What Lies Ahead For Exxon Stock Following Q1 Earnings?
The company is deriving high volume growth from its allied brands, which is expected to continue this year. The allied brands growth is included in the packaged beverage volumes for Dr Pepper, which is the distribution wing for these small but fast growing brands, such as Bai 5, Vita Coco, etc. Certain allied brands are experiencing both double- and triple-digit growth rates partially as a result of Dr Pepper’s specific focus on allied brand distribution and availability. At the gross margin line, the allied brands tend to carry lower gross margin because they have somebody else’s manufacturing profit in there, but are good contributors to Dr Pepper’s operating profitability. Allied brands form a small proportion of net volumes at present, but are an important factor of growth.
In 2016, Dr Pepper expects CSD volume to be flat, but NCB (non-carbonated beverages) growth to be up slightly. Pricing actions taken across several of the company’s warehouse direct brands are expected to hinder growth in NCB volume this year, however, continued growth from other brands such as Snapple, Clamato, and the allied brand portfolio should offset this decline. Despite tepid volume sales, a focus on packages that have higher price per volume, in both CSDs and non-CSD categories, will help Dr Pepper boost its top line over time.
Have more questions on Dr Pepper Snapple? See the links below.
- Dr Pepper Snapple Is Heavily Dependent On CSDs, But That’s Not A Problem
- Dr Pepper Beats Consensus Estimates; Grows Volume In Carbonated Beverages Too
- What’s Dr Pepper Snapple’s Revenue And EBITDA Breakdown?
- By What Percentage Have Dr Pepper Snapple’s Revenues And EBITDA Grown Over The Last Five Years?
- What’s Dr Pepper Snapple’s Fundamental Value Based On Expected 2016 Results?
- How Has Dr Pepper Snapple’s Revenue And EBITDA Composition Changed Over 2012-2016E?
- Why North America NCB Revenue Will Grow 5x North America CSD Revenue Over 2015-2018 For Dr Pepper
- Why Latin America Revenue Will Grow 2.5x North America Revenue Over 2015-2018 For Dr Pepper
- How Much Revenue Can Latin America Add By 2018 For Dr Pepper?
- Breakdown Of Dr Pepper’s U.S. CSD Vs Mexico CSD Presence
- How Much Can CSDs Add To Dr Pepper’s Top Line By 2018?
- How Much Can NCBs Add To Dr Pepper’s Top Line By 2018?
- 2015 Year In Review: Dr Pepper Snapple
Notes:
See More at Trefis | View Interactive Institutional Research (Powered by Trefis)